Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Κύριος συγγραφέας: | Moreino, Shannon Sherwin |
---|---|
Άλλοι συγγραφείς: | Kabir, Eva Rahman |
Μορφή: | Project report |
Γλώσσα: | English |
Έκδοση: |
BRAC University
2018
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/9331 |
Παρόμοια τεκμήρια
-
Biologics and Biosimilars as Treatment Options for Psoriasis
ανά: Moya, Amena Khatun
Έκδοση: (2023) -
Biosimilar in lymphoma treatment
ανά: Tanisha, Mehrin Haque
Έκδοση: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
ανά: Tabassum, Turana
Έκδοση: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
ανά: Tania, Umme
Έκδοση: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
ανά: Tania, Umme
Έκδοση: (2023)